Skip to main content

NRX Pharmaceuticals, Inc.

NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001719406

No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.

Superinvestors holding NRXP, Q2 2026

See all superinvestors

No superinvestor reported holding NRXP in Q2 2026.